Escaping the Plato's cave of latent tuberculosis testing: a path for developers of predictive tests for risk of tuberculosis

Morten Ruhwald, Roland Diel

Source: Eur Respir J, 52 (4) 1801616; 10.1183/13993003.01616-2018
Journal Issue: October
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Morten Ruhwald, Roland Diel. Escaping the Plato's cave of latent tuberculosis testing: a path for developers of predictive tests for risk of tuberculosis. Eur Respir J, 52 (4) 1801616; 10.1183/13993003.01616-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is science enough to tackle the epidemic?
Source: Eur Respir J 2007; 29: 423-427
Year: 2007

Active tuberculosis cases in migrants in Newham: should we extend screening criteria for latent tuberculosis infection
Source: International Congress 2017 – Migrants and screening
Year: 2017

Screening migrants for tuberculosis and latent TB infection: the reward will come later
Source: Eur Respir J, 54 (4) 1901719; 10.1183/13993003.01719-2019
Year: 2019

Predictive value of latent tuberculosis tests in Indian healthcare workers: a cohort study
Source: Eur Respir J 2011; 38: 1475-1477
Year: 2011

Framework for the evaluation of new tests for tuberculosis infection
Source: Eur Respir J, 58 (2) 2004078; 10.1183/13993003.04078-2020
Year: 2021

An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease
Source: Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018
Year: 2018

Screening healthcare workers for Mycobacterium TB: Is QFT-G now the test of choice?
Source: Annual Congress 2012 - Abestosis, silicosis and hypersensitivity pneumonitis
Year: 2012

Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice
Source: Eur Respir J 2011; 37: 1175-1182
Year: 2011

Value of BCG test and PPD test to assist the diagnosis of childhood tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 21s
Year: 2006

New immunologic tools for the diagnosis and therapy of tuberculosis
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005

Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection
Source: Eur Respir J 2016; 47: 919-928
Year: 2016

Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
Source: Eur Respir J 2016; 48: 1751-1763
Year: 2016

TB "cross-border" - a new challenge in tuberculosis management
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020

Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts
Source: Eur Respir J 2010; 35: 1346-1353
Year: 2010

Interpretation of indeterminate RIF-susceptibility results obtained by rapid molecular diagnostics test
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016

Using results of new laboratory test for tuberculosis infection in children
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Peculiarities of children's latent tuberculosis infection diagnostic in condition of ecological, social and economic crisis
Source: Eur Respir J 2002; 20: Suppl. 38, 115s
Year: 2002

Results of multicentral external quality assessment for M. tuberculosis drug susceptibility testing in Russia
Source: Eur Respir J 2005; 26: Suppl. 49, 646s
Year: 2005

Positive predictive value of an interferon-gamma release assay for progression from latent to active tuberculosis in new-entrant screening
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014

Novel drugs against tuberculosis: a clinician's perspective
Source: Eur Respir J 2015; 45: 1119-1131
Year: 2015